reports
Kien Giang Construction Investment Consultancy Group: 1 director
A director at Kien Giang Construction Investment Consultancy Group sold 200,000 shares at 0.000VND and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...
Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc 23-Apr-2024 / 13:52 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the tru...
Form 8.3 - The Vanguard Group, Inc.: Tyman plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Tyman plc 23-Apr-2024 / 13:54 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlo...
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc 23-Apr-2024 / 13:54 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), s...
Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc 23-Apr-2024 / 13:53 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
MAIA Biotechnology Announces $1.00 Million Private Placement
CHICAGO--(BUSINESS WIRE)-- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 494,096 shares of common stock at a purchase price of $2.034 per share, in a private placement to accredited investors and certain Company directors. Each share of common stock is being offered together with a warrant to purchase one share of common stock at an exercise price of $2.26 per share, whic...
Form 8.3 - Hipgnosis Songs Fund Limited
Form 8.3 - Hipgnosis Songs Fund Limited 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this ...
Encore Capital Group Expands Junior Achievement Partnership in the Uni...
Encore Capital Group Expands Junior Achievement Partnership in the United States to Empower Youth Through Financial Education Partnership Adds Financial Support, Expands Volunteer Opportunities Across Encore’s U.S. Locations SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (NASDAQ: ECPG), an international specialty finance company, today announced that it has established a partnership with , the nation’s largest organization dedicated to giving young people the knowledge and skills they need to own their economic success, plan for the future, and make smart acade...
Moody's Ratings assigns B3 rating to Motel One, positive outlook
Moody's Ratings (Moody's) today assigned a B3 corporate family rating to One Hotels GmbH ("Motel One"). Moody's also assigned a B3-PD probability of default rating and a B3 rating to the €800 million senior secured term loan B (TLB) due 2031 and the €100 million senior secured revolving credit facil...
Worthington Steel Named a 2023 Supplier of the Year by General Motors
COLUMBUS, Ohio--(BUSINESS WIRE)-- Worthington Steel, Inc. (NYSE: WS) today announced that it was named a GM Supplier of the Year winner in General Motors’ 32nd annual Supplier of the Year awards. This is the Company’s third time achieving this distinction. It previously won recognition in 2020 and 2021 as part of Worthington Industries. “Our employees and dedicated GM account team exemplify what it means to put our customers first. They are proactive, solution-focused and committed to finding new ways to add value every day,” said Worthington Steel president and CEO Geoff Gilmore. “We’re hon...
Sensirion Holding AG: 2 directors
A director at Sensirion Holding AG bought 11,342 shares at 58.141CHF and the significance rating of the trade was 88/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Poongsan Corporation: 1 director
A director at Poongsan Corporation sold 500 shares at 63,100.000KRW and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Alliance Entertainment to Host Fiscal Third Quarter 2024 Results Confe...
Alliance Entertainment to Host Fiscal Third Quarter 2024 Results Conference Call on Thursday, May 9, 2024 at 4:30 p.m. Eastern Time PLANTATION, Fla., April 23, 2024 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: ), a global distributor and wholesaler specializing in music, movies, video games, electronics, arcades, toys, and collectibles, will hold a conference call on Thursday, May 9, 2024 at 4:30 p.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2024. A press release detailing these results will be issued prior to the call. ...
Rigetti Computing Delivers Novera™ QPU to Horizon Quantum Computing fo...
Rigetti Computing Delivers Novera™ QPU to Horizon Quantum Computing for Singapore-Based Hardware Testbed Rigetti sells Novera QPU to Horizon Quantum Computing for its first quantum computing system in its newly opened hardware testbed in Singapore. BERKELEY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, announces the sale of a Novera™ quantum processing unit (QPU) to Horizon Quantum Computing. This marks the Company’s third sale of a Novera QPU, and is the Company’s fir...
Adeia Enters into Multi-year IP License Renewal with Altimedia
Adeia Enters into Multi-year IP License Renewal with Altimedia SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), a company known for its groundbreaking innovations in entertainment experiences, has announced today that Altimedia, a provider of solutions for managing advanced media services, has signed a multi-year license renewal for access to Adeia’s media intellectual property (IP) portfolio. Altimedia offers a user experience (UX) platform to pay-TV and digital media service providers in the Korean market. Their platform empowers these providers with cutt...
PaxMedica Responds to Emergency Request for IV Suramin and Commits to ...
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (Nasdaq: PXMD) (the “Company”), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, expects to take immediate action in response to an urgent request for IV suramin from the Ministry of Health (MOH) of Malawi, a country in east Africa. The request seeks emergency access to the Company’s recently completed registration batches of PAX-101 (IV suramin) to addres...
GeneDx Announces Partnership with Komodo Health to Expand Access to Wo...
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, a premier healthcare technology company for the pharmaceutical industry. The new partnership will increase access to GeneDx's...
NewtekOne, Inc. CEO, Barry Sloane, to Attend the B. Riley Securities 2...
NewtekOne, Inc. CEO, Barry Sloane, to Attend the B. Riley Securities 24th Institutional Investor Conference May 22-23, 2024 BOCA RATON, Fla., April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: NEWT), announced today that NewtekOne’s CEO and President, Barry Sloane, and CFO, M. Scott Price, will attend and hold-one-on-one meetings at the B. Riley Securities 24th Institutional Investor Conference on May 22-23, 2024 at the Beverly Hilton Hotel in Beverly Hills, CA. To schedule a meeting, please contact your B. Riley representative, or Jayne Cavuoto, Director of Investor Relations at NewtekOne, at ...
KULR Delivers Immediate Power Cell Battery Deployment Order for AI-Ena...
KULR Delivers Immediate Power Cell Battery Deployment Order for AI-Enabled Drone Missions in Ukraine SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- (NYSE American: KULR) (the "Company" or "KULR"), a global leader in sustainable energy management, today announced it has delivered on an immediate basis, a power cell battery deployment order for AI-enabled drone and advanced air mobility missions in Ukraine. The Ukrainian contractor will employ the Company's high-power battery cells to sustain its ongoing drone operations in Eastern Europe. This initial deployment order necessitated immediat...
Palisade Bio Enters into Strategic Collaboration with Strand Life Scie...
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach – Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving milestone in Palisade Bio's mission to redefine UC treatment through targeted interventions based on PDE4-related biomarkers Carlsbad, CA, April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeut...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.